ICAD INC. - COMMON STO
1.7300
29-November-24 13:45:00
15 minutes delayed
Stocks
-0.0400
-2.26%
Today's range
1.6700 - 1.8900
ISIN
N/A
Source
NASDAQ
-
iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition
05 Apr 2021 16:01:00 By Nasdaq GlobeNewswire
-
New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates
31 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
-
iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography
15 Mar 2021 18:04:42 By Nasdaq GlobeNewswire
-
New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting
08 Mar 2021 12:36:23 By Nasdaq GlobeNewswire
-
iCAD to Participate in the Cowen 41st Annual Health Care Conference
03 Mar 2021 21:16:22 By Nasdaq GlobeNewswire
-
iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock
03 Mar 2021 00:47:48 By Nasdaq GlobeNewswire
-
iCAD Announces Proposed Public Offering of Common Stock
02 Mar 2021 16:01:00 By Nasdaq GlobeNewswire
-
iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020
24 Feb 2021 16:01:01 By Nasdaq GlobeNewswire
-
iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24
18 Feb 2021 18:56:26 By Nasdaq GlobeNewswire
-
16 Feb 2021 16:01:00 By Nasdaq GlobeNewswire
-
iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference
19 Jan 2021 08:00:02 By Nasdaq GlobeNewswire
-
iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
06 Jan 2021 16:01:00 By Nasdaq GlobeNewswire